Risk Factors Update Summary
- Increase in accounts receivable balances for major customers from 19% to 77%. Higher credit risk.
- Received notices of allowances for patent applications for treating Alzheimer's disease. This enhances our intellectual property portfolio.
- Josh Fine appointed as Financial Officer. Change in leadership may impact operational management.
- Supply contract impacts operations, financial condition, and cash flows. Dependency risk on single supplier.
- Decrease from three to two major customers accounting for 72% of total revenues. Diversification risk.
- Notices of non-compliance with Nasdaq regulatory requirements received. Risk of delisting.
Full Text Changes in Most Recent 10-K
Intended use: review the highlighted statements. These are additions to the risk factors disclosure in the most recent 10-K filing compared to the previous 10-K filing. Deleted and moved text is less important and is shown for context.
To view the full company filings, click on the following link to be taken to the SEC EDGAR database landing page for the company: https://www.sec.gov/edgar/browse/?CIK=922247&owner=exclude
This content requires a 'Free' membership to view. Please create one here.
This content requires a 'Free' membership to view. Please create one here.